Stock Purchase AgreementStock Purchase Agreement • March 19th, 2014 • Five Prime Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 19th, 2014 Company Industry JurisdictionThis Stock Purchase Agreement (this “Agreement”), effective as of March 14, 2014 (the “Effective Date”), is entered into by and between Bristol-Myers Squibb Company, a Delaware corporation (“BMS”), and Five Prime Therapeutics, Inc., a Delaware corporation (“FivePrime”). BMS and FivePrime are referred to individually as a “Party” and collectively as the “Parties”.